Antibody Engineering: Shaping the Future of Therapeutics

Next-generation antibodies represent a leap forward in personalized healthcare, integrating advanced molecular engineering and computational design. These antibodies can be customized to recognize unique tumor neoantigens or patient-specific pathogenic epitopes. Innovations like antibody fragments, Fc engineering for improved half-life, and glycoengineering for optimized immune responses are tailoring treatments to patient genetics, improving therapeutic windows and reducing off-target effects. This precision approach is essential for diseases with high heterogeneity like cancers and autoimmune disorders.